Schizophrenia Clinical Trials

Find Schizophrenia Clinical Trials Near You

Efficiency Assessment of a Mental Health Professionals' Training Course for a Short Psychoeducational Program (BREF) for Families and Caregivers of Patients With Schizophrenia or First Psychotic Episode.

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In psychiatry, caregiver burden is associated with excess physical and psychological morbidity in relatives of patients with schizophrenic disorders Single or multi-family psychoeducation for caregivers of patients with schizophrenic disorders or first episode psychosis has a direct benefit on the health of the caregiver and an indirect benefit on the health of the ill family member. It is associated with a reduction in the rate of relapse and re-hospitalization and with better compliance with treatment. For single-family psychoeducation, the number of caregivers to be treated to avoid re-hospitalization of the sick family member is 3. For caregivers, psychoeducation is accompanied by an improvement in knowledge of the disorders and coping strategies. Therefore, international recommendations recommend that psychoeducation for caregivers be systematic, early, and integrated into routine care. Currently, the organization of the French care system does not allow these recommendations to be met. In order to increase the use of psychoeducation in France, early interventions for caregivers must be offered systematically. The effectiveness of early psychoeducation for caregivers needs to be evaluated; only three randomized controlled trials are available in the literature and none have been conducted in France.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• people over 18yo

• first-degree relatives (parents, siblings, children) or spouse of the patient

• primary caregiver of a patient with schizophrenic disorders or first psychotic episode (DSM5)

• consenting to participate to the study

Locations
Other Locations
France
Hopital Vinatier
RECRUITING
Bron
Contact Information
Primary
Romain REY, MD, PhD
romain.rey@ch-le-vinatier.fr
+33437915495
Backup
Anne-Lise BOHEC, PhD
Anne-lise.BOHEC@ch-le-vinatier.fr
+33437915495
Time Frame
Start Date: 2022-04-05
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 206
Treatments
Active_comparator: Control group
The design is a stepped-wedge cluster randomized controlled trial. The study will be conducted in 9 centers (clusters) and will be conducted in 6 successive phases of 4 months each.~During the first period, groups will be in the control period, then sequentially and according to a randomly defined order, at each time, one group will go into the intervention period after a transition period of 4 months allowing the intervention to be deployed (training of three health professionals for each center and then implementation of the BREF program).~Thus, each cluster will belong successively to the control group and the intervention group. During the control period, caregivers will be supported according to the usual practices of each center. During the intervention period, the BREF program will be offered to all eligible caregivers.
Experimental: intervention group
Thus, each cluster will belong successively to the control group and the intervention group. During the intervention period, the BREF program will be offered to all eligible caregivers.
Related Therapeutic Areas
Sponsors
Leads: Hôpital le Vinatier

This content was sourced from clinicaltrials.gov